Welcome to visit Zhongnan Medical Journal Press Series journal website!
Zhongnan Medical Journal Press
Series of Journals
Center for Evidence-Based and Translational Medicine of Wuhan University
The title
The title
The keywords
The author
Submit
Home
About us
Journal Introduction
Chief Editor
Editorial Committee
Author Center
Submission Guide
Assignment Agreement
ConflictofInterest
Articles
Subscribe
Copyright
Contact us
Draft submission system
Author login
Author register
Reviewer login
Editor login
Home
Articles
Vol 34,2025 No.3
The title
The title
The keywords
The author
New Online
Vol 34,2025
Vol 33,2024
Vol 32,2023
No.3
No.2
No.1
Contents
Vol 34,2025 No.3
Date of publication: March 15, 2025
Get cover
Get contents
Prev
Vol 34,2025 No.2
Interpretation of the Guide on Methodological Standards in Pharmacoepidemiology in China (2nd edition) (III): comparison of global guidelines
YAN Jinan
WU Yunxiao
NIE Xiaolu
ZHAO Houyu
ZHAN Siyan
SUN Feng
2025,34(3):241-259
Pharmacoepidemiology
Methodological guideline
Systematic review
Details
Download
Mobile
Medication rules and mechanism of Xin’an physicians in the treatment of diabetes mellitus based on data mining and network pharmacology
ZHU Jinru
WU Qing
HU Kexin
WANG Mengfan
FANG Zhaohui
2025,34(3):260-272
Xin’an medicine
Diabetes mellitus
Data mining
Network pharmacology
Medication rule
Mechanism of action
Details
Download
Mobile
Questionnaire survey on knowledge, attitude and practice of doctors and pharmacists regarding allergic reactions to iodine contrast agent
LIU Chen
BAI Xiangrong
CHU Yanqi
XING Xiaoxuan
QIU Yujie
2025,34(3):273-281
Doctors
Pharmacists
Contrast agent
Allergic reactions
Knowledge
attitude and practice
Questionnaire survey
Details
Download
Mobile
The role of PCSK9 in regulating the biological function and ferroptosis sensitivity of prostate cancer cells
WANG Shichun
SHI Minghui
WANG Danqi
XI Shu
CUI Jinlong
LIU Shuyan
YUAN Shuai
JIN Yinghui
2025,34(3):282-292
Prostate cancer
Proprotein convertase subtilisin/kexin type 9
Proliferation
Migration
Invasion
Ferroptosis
Details
Download
Mobile
The incidence of antibiotic-associated diarrhea in critically ill patients in China: a Meta-analysis
FAN Bingxin
HUANG Li
WU Hao
LI Jialing
XIAO Rong
WANG Zhi
WANG Yudi
LIU Surong
2025,34(3):293-305
Antibiotic associated diarrhea
Critically ill patients
Incidence rate
Meta-analysis
Details
Download
Mobile
Vonoprazan for ulcers associated with endoscopic submucosal dissection: a rapid health technology assessment
WANG Wei
KE Yijun
CHENG Chang
FANG Chongwen
PAN Lisheng
JIN Yong
ZHANG Yanping
2025,34(3):306-313
Vonoprazan
Endoscopic submucosal dissection
Ulcer
Rapid health technology assessment
Details
Download
Mobile
Venetoclax in the treatment of non-M3 acute myeloid leukemia: a rapid health technology assessment
ZHANG Yazhuo
LI Huiling
Duan Yinyin
SHI Yuye
2025,34(3):314-323
Venetoclax
Non-M3 acute myeloid leukemia
Rapid health technology assessment
Details
Download
Mobile
Literature analysis of adverse reactions induced by olaparib
WANG Jialing
ZOU Dong
2025,34(3):324-332
Olaparib
Adverse drug reactions
Case report
Literature analysis
Details
Download
Mobile
Research progress of trifluridine-tipiracil and probiotics in colorectal cancer
LI Shiqi
SU Riguga
YANG Yuchen
ZHAO Yuting
GONG Jiayu
ZHANG Jiao
CAI Zhihui
2025,34(3):333-340
Trifluridine-tipiracil
Colorectal cancer
Probiotics
Combination therapy
Details
Download
Mobile
Clinical pharmacist participated in a case study of a severe immune-related cholestatic liver injury case induced by camrelizumab
YUWEN Lixia
HE Yunhao
YUAN Yaohui
2025,34(3):341-345
Clinical pharmacist
Camrelizumab
Liver injury
Cholestatic
Immunotherapy
Details
Download
Mobile
A case of ketoacidosis due to type 2 diabetes treated with semaglutide combined with ertugliflozin
ZHANG Min
XU Yuan
LI Juan
2025,34(3):346-352
Semaglutide
Ertugliflozin
Diabetic ketoacidosis
Adverse drug reactions
Details
Download
Mobile
A case of acute kidney injury due to suspected omadacycline
LIN Huan
YU Xiuheng
HUANG Xiaobin
ZHAO Yu
2025,34(3):353-358
Omadacycline
Acute kidney injury
Adverse drug reaction
Case report
Details
Download
Mobile
A case report of immune-related multisystem adverse reactions caused by tislelizumab
SONG Qiuyan
TAI Qirui
ZHANG Bikui
LUO Zhiying
SUN Bao
LIU Wenhui
2025,34(3):359-364
Tislelizumab
Myasthenia gravis
Myositis
Myocarditis
Liver function damage
Immune-related adverse reaction
Details
Download
Mobile